How are you taking part in this consultation?

You will not be able to change how you comment later.

You must be signed in to answer questions

  • Question on Consultation

    Has all of the relevant evidence been taken into account?
  • Question on Consultation

    Are the summaries of clinical and cost effectiveness reasonable interpretations of the evidence?
  • Question on Consultation

    Are the recommendations sound and a suitable basis for guidance to the NHS?
  • Question on Consultation

    Are there any equality issues that need special consideration and are not covered in the medical technology consultation document?
The content on this page is not current guidance and is only for the purposes of the consultation process.

4 Committee members

This topic was considered by NICE's medical technologies advisory committee, which is a standing advisory committee of NICE.

Committee members are asked to declare any interests in the technology to be evaluated. If it is considered there is a conflict of interest, the member is excluded from participating further in that evaluation.

The minutes of each committee meeting, which include the names of the members who attended and their declarations of interests, are posted on the NICE website.

NICE also recruited clinical experts and specialist committee members for this topic.

Specialist committee members

Leanne Atkin
Vascular nurse consultant, Mid Yorkshire NHS Trust

Priti Bhatt
Tissue viability specialist nurse lead for community services, Guy's and St Thomas' NHS Foundation Trust

Jo Dumville
Professor of applied health research, University of Manchester

Mark Dunne Willows
Lay specialist committee member

Alan Leslie Elstone
Vascular nurse specialist and advanced clinical practitioner, University Hospitals Plymouth NHS Trust

Megan Leach
Lay specialist committee member

Julie Thackray
Vascular nurse specialist, Leeds Teaching Hospitals NHS Trust

Jane Todhunter
Vascular nurse practitioner, North Cumbria Integrated Care NHS Foundation Trust

Clinical experts

Hannah Blake
Tissue viability clinical nurse specialist, Livewell Southwest

Debera Drew
Tissue viability specialist nurse and senior community research nurse, Northumbria Healthcare Foundation Trust

Stacey Evans-Charles
Tissue viability lead nurse, NHS Highland

Rachael Lee
Acting programme manager, National Wound Care Strategy Programme

Nicky Morton
Supply and distribution workstream lead, National Wound Care Strategy Programme

Maria Poole
Support consultant, The Lindsay Leg Club Foundation

Beverly Wright
Tissue viability operational lead, Northumbria Healthcare NHS Foundation Trust

NICE project team

Each evaluation is assigned to a team consisting of 1 or more health technology analysts (who act as technical leads for the evaluation), a technical adviser, a project manager and an associate director.

Lirije Hyseni and Ahmed Yosef
Technical leads

Bernice Dillon
Technical adviser

Catherine Pank
Project manager

Emily Eaton Turner
Associate director

ISBN: [to be added at publication]